Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy - Centre de recherche des Cordeliers Access content directly
Preprints, Working Papers, ... Year : 2022

Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy


Hepatocellular carcinoma is the most prevalent form of primary liver cancer with a multifactorial aetiology comprising genetic, environmental, and behavioural factors. Evading cell death is a defining hallmark of hepatocellular carcinoma, underpinning tumour growth, progression, and therapy resistance. Ferroptosis is a form of nonapoptotic cell death driven by an array of cellular events, including intracellular iron overload, free radical production, lipid peroxidation and activation of various cell death effectors, ultimately leading to rupture of the plasma membrane. Although induction of ferroptosis is an emerging strategy to suppress hepatocellular carcinoma, malignant cells manage to develop adaptive mechanisms, conferring resistance to ferroptosis and ferroptosis-inducing drugs. Herein, we aim at elucidating molecular mechanisms and signalling pathways involved in ferroptosis and offer our opinions on druggable targets and new therapeutic strategy in an attempt to restrain the growth and progression of hepatocellular carcinoma through induction of ferroptotic cell death.
Fichier principal
Vignette du fichier
36229582.pdf (3.45 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04596747 , version 1 (12-06-2024)



Amir Ajoolabady, Daolin Tang, Guido Kroemer, Jun Ren. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. 2024. ⟨hal-04596747⟩
41 View
1 Download



Gmail Mastodon Facebook X LinkedIn More